nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—DRD2—nicotine dependence	0.742	1	CbGaD
Trimipramine—Withdrawal symptom—Varenicline—nicotine dependence	0.0092	0.0724	CcSEcCtD
Trimipramine—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.00769	0.0606	CcSEcCtD
Trimipramine—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.00727	0.0573	CcSEcCtD
Trimipramine—Delusion—Varenicline—nicotine dependence	0.00533	0.042	CcSEcCtD
Trimipramine—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00501	0.0394	CcSEcCtD
Trimipramine—Mydriasis—Varenicline—nicotine dependence	0.00473	0.0372	CcSEcCtD
Trimipramine—Coordination abnormal—Varenicline—nicotine dependence	0.00384	0.0302	CcSEcCtD
Trimipramine—Nightmare—Varenicline—nicotine dependence	0.00364	0.0287	CcSEcCtD
Trimipramine—Disorientation—Varenicline—nicotine dependence	0.00306	0.0241	CcSEcCtD
Trimipramine—Libido decreased—Varenicline—nicotine dependence	0.00295	0.0233	CcSEcCtD
Trimipramine—Cerebrovascular accident—Varenicline—nicotine dependence	0.0028	0.022	CcSEcCtD
Trimipramine—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00272	0.0214	CcSEcCtD
Trimipramine—Psychotic disorder—Varenicline—nicotine dependence	0.00268	0.0211	CcSEcCtD
Trimipramine—Urinary retention—Varenicline—nicotine dependence	0.0026	0.0205	CcSEcCtD
Trimipramine—Pollakiuria—Varenicline—nicotine dependence	0.00219	0.0172	CcSEcCtD
Trimipramine—Erectile dysfunction—Varenicline—nicotine dependence	0.00218	0.0172	CcSEcCtD
Trimipramine—Weight increased—Varenicline—nicotine dependence	0.00215	0.017	CcSEcCtD
Trimipramine—Acute coronary syndrome—Varenicline—nicotine dependence	0.00208	0.0164	CcSEcCtD
Trimipramine—Myocardial infarction—Varenicline—nicotine dependence	0.00207	0.0163	CcSEcCtD
Trimipramine—Stomatitis—Varenicline—nicotine dependence	0.00206	0.0162	CcSEcCtD
Trimipramine—Methadone—CHRNA10—nicotine dependence	0.00199	0.261	CrCbGaD
Trimipramine—Hypoaesthesia—Varenicline—nicotine dependence	0.00189	0.0148	CcSEcCtD
Trimipramine—Hallucination—Varenicline—nicotine dependence	0.00189	0.0148	CcSEcCtD
Trimipramine—Tinnitus—Varenicline—nicotine dependence	0.00177	0.0139	CcSEcCtD
Trimipramine—Arrhythmia—Varenicline—nicotine dependence	0.00169	0.0133	CcSEcCtD
Trimipramine—Dysgeusia—Varenicline—nicotine dependence	0.00162	0.0127	CcSEcCtD
Trimipramine—Vision blurred—Varenicline—nicotine dependence	0.00155	0.0122	CcSEcCtD
Trimipramine—Tremor—Varenicline—nicotine dependence	0.00155	0.0122	CcSEcCtD
Trimipramine—Ill-defined disorder—Varenicline—nicotine dependence	0.00153	0.012	CcSEcCtD
Trimipramine—Agitation—Varenicline—nicotine dependence	0.00152	0.0119	CcSEcCtD
Trimipramine—Malaise—Varenicline—nicotine dependence	0.00149	0.0117	CcSEcCtD
Trimipramine—Palpitations—Varenicline—nicotine dependence	0.00146	0.0115	CcSEcCtD
Trimipramine—Convulsion—Varenicline—nicotine dependence	0.00143	0.0113	CcSEcCtD
Trimipramine—Hypertension—Varenicline—nicotine dependence	0.00142	0.0112	CcSEcCtD
Trimipramine—Anxiety—Varenicline—nicotine dependence	0.0014	0.011	CcSEcCtD
Trimipramine—Discomfort—Varenicline—nicotine dependence	0.00139	0.0109	CcSEcCtD
Trimipramine—Dry mouth—Varenicline—nicotine dependence	0.00137	0.0108	CcSEcCtD
Trimipramine—Oedema—Varenicline—nicotine dependence	0.00135	0.0106	CcSEcCtD
Trimipramine—Thrombocytopenia—Varenicline—nicotine dependence	0.00132	0.0104	CcSEcCtD
Trimipramine—Tachycardia—Varenicline—nicotine dependence	0.00131	0.0103	CcSEcCtD
Trimipramine—Anorexia—Varenicline—nicotine dependence	0.00128	0.0101	CcSEcCtD
Trimipramine—Hypotension—Varenicline—nicotine dependence	0.00126	0.0099	CcSEcCtD
Trimipramine—HTR1D—cardiovascular system—nicotine dependence	0.00125	0.0648	CbGeAlD
Trimipramine—Insomnia—Varenicline—nicotine dependence	0.00122	0.00959	CcSEcCtD
Trimipramine—Somnolence—Varenicline—nicotine dependence	0.0012	0.00942	CcSEcCtD
Trimipramine—Dyspepsia—Varenicline—nicotine dependence	0.00119	0.00933	CcSEcCtD
Trimipramine—Decreased appetite—Varenicline—nicotine dependence	0.00117	0.00921	CcSEcCtD
Trimipramine—Fatigue—Varenicline—nicotine dependence	0.00116	0.00914	CcSEcCtD
Trimipramine—Constipation—Varenicline—nicotine dependence	0.00115	0.00906	CcSEcCtD
Trimipramine—Feeling abnormal—Varenicline—nicotine dependence	0.00111	0.00873	CcSEcCtD
Trimipramine—Urticaria—Varenicline—nicotine dependence	0.00107	0.00842	CcSEcCtD
Trimipramine—Abdominal pain—Varenicline—nicotine dependence	0.00106	0.00838	CcSEcCtD
Trimipramine—Body temperature increased—Varenicline—nicotine dependence	0.00106	0.00838	CcSEcCtD
Trimipramine—HTR1A—cardiovascular system—nicotine dependence	0.00104	0.054	CbGeAlD
Trimipramine—SLC6A3—midbrain—nicotine dependence	0.001	0.0518	CbGeAlD
Trimipramine—HTR1D—midbrain—nicotine dependence	0.000978	0.0506	CbGeAlD
Trimipramine—HTR2C—midbrain—nicotine dependence	0.000969	0.0501	CbGeAlD
Trimipramine—Asthenia—Varenicline—nicotine dependence	0.000966	0.0076	CcSEcCtD
Trimipramine—ADRA1A—cardiovascular system—nicotine dependence	0.000963	0.0498	CbGeAlD
Trimipramine—Pruritus—Varenicline—nicotine dependence	0.000953	0.0075	CcSEcCtD
Trimipramine—Diarrhoea—Varenicline—nicotine dependence	0.000921	0.00725	CcSEcCtD
Trimipramine—SLC6A4—midbrain—nicotine dependence	0.000919	0.0475	CbGeAlD
Trimipramine—Dizziness—Varenicline—nicotine dependence	0.00089	0.00701	CcSEcCtD
Trimipramine—Vomiting—Varenicline—nicotine dependence	0.000856	0.00674	CcSEcCtD
Trimipramine—Rash—Varenicline—nicotine dependence	0.000849	0.00668	CcSEcCtD
Trimipramine—Dermatitis—Varenicline—nicotine dependence	0.000848	0.00668	CcSEcCtD
Trimipramine—Headache—Varenicline—nicotine dependence	0.000843	0.00664	CcSEcCtD
Trimipramine—ADRA1B—brain—nicotine dependence	0.000841	0.0435	CbGeAlD
Trimipramine—Dextropropoxyphene—OPRM1—nicotine dependence	0.000833	0.109	CrCbGaD
Trimipramine—HTR1A—midbrain—nicotine dependence	0.000816	0.0422	CbGeAlD
Trimipramine—Nausea—Varenicline—nicotine dependence	0.0008	0.0063	CcSEcCtD
Trimipramine—HTR3A—brain—nicotine dependence	0.000757	0.0391	CbGeAlD
Trimipramine—CYP2C9—cardiovascular system—nicotine dependence	0.000756	0.0391	CbGeAlD
Trimipramine—DRD2—midbrain—nicotine dependence	0.000737	0.0381	CbGeAlD
Trimipramine—SLC6A3—brain—nicotine dependence	0.00063	0.0326	CbGeAlD
Trimipramine—HTR2A—cardiovascular system—nicotine dependence	0.000622	0.0322	CbGeAlD
Trimipramine—HTR1D—brain—nicotine dependence	0.000615	0.0318	CbGeAlD
Trimipramine—HTR2C—brain—nicotine dependence	0.000609	0.0315	CbGeAlD
Trimipramine—SLC6A4—brain—nicotine dependence	0.000577	0.0298	CbGeAlD
Trimipramine—ADRA2A—midbrain—nicotine dependence	0.000572	0.0296	CbGeAlD
Trimipramine—Methadone—OPRM1—nicotine dependence	0.000565	0.0739	CrCbGaD
Trimipramine—HTR1A—brain—nicotine dependence	0.000512	0.0265	CbGeAlD
Trimipramine—SLC6A2—brain—nicotine dependence	0.000508	0.0263	CbGeAlD
Trimipramine—HTR2A—midbrain—nicotine dependence	0.000486	0.0251	CbGeAlD
Trimipramine—ADRA1A—brain—nicotine dependence	0.000472	0.0244	CbGeAlD
Trimipramine—Acepromazine—DRD2—nicotine dependence	0.000467	0.0611	CrCbGaD
Trimipramine—DRD2—brain—nicotine dependence	0.000463	0.0239	CbGeAlD
Trimipramine—Amitriptyline—OPRM1—nicotine dependence	0.000439	0.0575	CrCbGaD
Trimipramine—ABCB1—cardiovascular system—nicotine dependence	0.000408	0.0211	CbGeAlD
Trimipramine—Mianserin—DRD2—nicotine dependence	0.000388	0.0508	CrCbGaD
Trimipramine—Propiomazine—DRD2—nicotine dependence	0.000373	0.0489	CrCbGaD
Trimipramine—HRH1—brain—nicotine dependence	0.000366	0.0189	CbGeAlD
Trimipramine—ADRA2A—brain—nicotine dependence	0.000359	0.0186	CbGeAlD
Trimipramine—Nortriptyline—DRD2—nicotine dependence	0.000347	0.0454	CrCbGaD
Trimipramine—SLC6A3—Neuronal System—CHRNA5—nicotine dependence	0.000332	0.0032	CbGpPWpGaD
Trimipramine—DRD2—GPCR ligand binding—TAS2R16—nicotine dependence	0.000322	0.00311	CbGpPWpGaD
Trimipramine—Methotrimeprazine—DRD2—nicotine dependence	0.000319	0.0418	CrCbGaD
Trimipramine—ABCB1—midbrain—nicotine dependence	0.000319	0.0165	CbGeAlD
Trimipramine—HTR1D—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000318	0.00306	CbGpPWpGaD
Trimipramine—HTR2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000317	0.00306	CbGpPWpGaD
Trimipramine—HRH1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000316	0.00305	CbGpPWpGaD
Trimipramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000316	0.00305	CbGpPWpGaD
Trimipramine—HTR1A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000315	0.00304	CbGpPWpGaD
Trimipramine—Promethazine—DRD2—nicotine dependence	0.000314	0.0412	CrCbGaD
Trimipramine—Doxepin—DRD2—nicotine dependence	0.000311	0.0407	CrCbGaD
Trimipramine—SLC6A3—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000311	0.003	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000311	0.00299	CbGpPWpGaD
Trimipramine—HTR2A—brain—nicotine dependence	0.000305	0.0158	CbGeAlD
Trimipramine—SLC6A4—Circadian rythm related genes—DRD2—nicotine dependence	0.000301	0.0029	CbGpPWpGaD
Trimipramine—HTR2A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.0003	0.00289	CbGpPWpGaD
Trimipramine—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000296	0.00286	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000289	0.00278	CbGpPWpGaD
Trimipramine—Desipramine—DRD2—nicotine dependence	0.000285	0.0374	CrCbGaD
Trimipramine—SLC6A3—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000282	0.00272	CbGpPWpGaD
Trimipramine—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000279	0.00269	CbGpPWpGaD
Trimipramine—CYP2D6—brain—nicotine dependence	0.000278	0.0144	CbGeAlD
Trimipramine—HTR1D—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000278	0.00268	CbGpPWpGaD
Trimipramine—Promazine—DRD2—nicotine dependence	0.000277	0.0362	CrCbGaD
Trimipramine—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000275	0.00265	CbGpPWpGaD
Trimipramine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000272	0.00263	CbGpPWpGaD
Trimipramine—HTR1D—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000272	0.00263	CbGpPWpGaD
Trimipramine—HTR2A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000272	0.00262	CbGpPWpGaD
Trimipramine—SLC6A3—Neuronal System—CHRNA3—nicotine dependence	0.000271	0.00261	CbGpPWpGaD
Trimipramine—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00027	0.0026	CbGpPWpGaD
Trimipramine—ADRA2B—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000265	0.00255	CbGpPWpGaD
Trimipramine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000257	0.00248	CbGpPWpGaD
Trimipramine—HTR1A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000256	0.00246	CbGpPWpGaD
Trimipramine—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000255	0.00245	CbGpPWpGaD
Trimipramine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000253	0.00244	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—TAS2R16—nicotine dependence	0.000253	0.00243	CbGpPWpGaD
Trimipramine—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000251	0.00242	CbGpPWpGaD
Trimipramine—DRD2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000249	0.0024	CbGpPWpGaD
Trimipramine—HTR1D—G alpha (i) signalling events—DRD2—nicotine dependence	0.000248	0.00239	CbGpPWpGaD
Trimipramine—ADRA2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000246	0.00237	CbGpPWpGaD
Trimipramine—Chlorpromazine—DRD2—nicotine dependence	0.000243	0.0319	CrCbGaD
Trimipramine—Imipramine—DRD2—nicotine dependence	0.000242	0.0317	CrCbGaD
Trimipramine—Amitriptyline—DRD2—nicotine dependence	0.000241	0.0315	CrCbGaD
Trimipramine—SLC6A3—Neuronal System—CHRNB2—nicotine dependence	0.000238	0.0023	CbGpPWpGaD
Trimipramine—HTR1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000237	0.00229	CbGpPWpGaD
Trimipramine—HTR2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000236	0.00227	CbGpPWpGaD
Trimipramine—HTR1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00023	0.00222	CbGpPWpGaD
Trimipramine—SLC6A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000226	0.00218	CbGpPWpGaD
Trimipramine—ADRA1B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000226	0.00218	CbGpPWpGaD
Trimipramine—DRD2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000224	0.00216	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—FGD1—nicotine dependence	0.000218	0.0021	CbGpPWpGaD
Trimipramine—SLC6A3—Neuronal System—CHRNA4—nicotine dependence	0.000216	0.00208	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000215	0.00207	CbGpPWpGaD
Trimipramine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000211	0.00203	CbGpPWpGaD
Trimipramine—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000208	0.00201	CbGpPWpGaD
Trimipramine—HTR1D—GPCR ligand binding—OPRM1—nicotine dependence	0.000207	0.002	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000207	0.002	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000206	0.00199	CbGpPWpGaD
Trimipramine—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000205	0.00197	CbGpPWpGaD
Trimipramine—HRH1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000204	0.00197	CbGpPWpGaD
Trimipramine—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000203	0.00196	CbGpPWpGaD
Trimipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000202	0.00195	CbGpPWpGaD
Trimipramine—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000201	0.00194	CbGpPWpGaD
Trimipramine—ADRA1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000201	0.00193	CbGpPWpGaD
Trimipramine—SLC6A3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.0002	0.00193	CbGpPWpGaD
Trimipramine—ABCB1—brain—nicotine dependence	0.0002	0.0103	CbGeAlD
Trimipramine—HTR1D—Signaling by GPCR—FGD1—nicotine dependence	0.000198	0.00191	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000198	0.0019	CbGpPWpGaD
Trimipramine—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000197	0.0019	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000195	0.00188	CbGpPWpGaD
Trimipramine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000194	0.00187	CbGpPWpGaD
Trimipramine—ADRA2B—G alpha (i) signalling events—DRD2—nicotine dependence	0.000191	0.00184	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000188	0.00182	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.000187	0.00181	CbGpPWpGaD
Trimipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000186	0.0018	CbGpPWpGaD
Trimipramine—HTR1A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000185	0.00178	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000182	0.00176	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000179	0.00173	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000179	0.00173	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000179	0.00172	CbGpPWpGaD
Trimipramine—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000178	0.00172	CbGpPWpGaD
Trimipramine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000178	0.00172	CbGpPWpGaD
Trimipramine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000178	0.00171	CbGpPWpGaD
Trimipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000176	0.00169	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000175	0.00169	CbGpPWpGaD
Trimipramine—HRH1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000175	0.00169	CbGpPWpGaD
Trimipramine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000172	0.00166	CbGpPWpGaD
Trimipramine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000171	0.00165	CbGpPWpGaD
Trimipramine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000171	0.00164	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.000169	0.00163	CbGpPWpGaD
Trimipramine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000168	0.00162	CbGpPWpGaD
Trimipramine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000166	0.0016	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000165	0.00159	CbGpPWpGaD
Trimipramine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000163	0.00157	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000163	0.00157	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000163	0.00157	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000163	0.00157	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000162	0.00157	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000162	0.00156	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.00016	0.00154	CbGpPWpGaD
Trimipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00016	0.00154	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000159	0.00154	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.000155	0.00149	CbGpPWpGaD
Trimipramine—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000155	0.00149	CbGpPWpGaD
Trimipramine—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000154	0.00148	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—FGD1—nicotine dependence	0.000153	0.00148	CbGpPWpGaD
Trimipramine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000152	0.00147	CbGpPWpGaD
Trimipramine—HTR1D—GPCR ligand binding—DRD2—nicotine dependence	0.00015	0.00145	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000149	0.00144	CbGpPWpGaD
Trimipramine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000148	0.00143	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000148	0.00143	CbGpPWpGaD
Trimipramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000148	0.00142	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000148	0.00142	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.000147	0.00142	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000147	0.00142	CbGpPWpGaD
Trimipramine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000147	0.00142	CbGpPWpGaD
Trimipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000146	0.00141	CbGpPWpGaD
Trimipramine—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000145	0.0014	CbGpPWpGaD
Trimipramine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000145	0.0014	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000143	0.00138	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.000141	0.00136	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000141	0.00136	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	0.00014	0.00135	CbGpPWpGaD
Trimipramine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00014	0.00135	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000138	0.00133	CbGpPWpGaD
Trimipramine—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000136	0.00131	CbGpPWpGaD
Trimipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000135	0.0013	CbGpPWpGaD
Trimipramine—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000134	0.00129	CbGpPWpGaD
Trimipramine—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	0.000133	0.00129	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000131	0.00126	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.00013	0.00125	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000128	0.00123	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.000128	0.00123	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—FGD1—nicotine dependence	0.000127	0.00123	CbGpPWpGaD
Trimipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000127	0.00122	CbGpPWpGaD
Trimipramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000127	0.00122	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.000125	0.00121	CbGpPWpGaD
Trimipramine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000124	0.0012	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000122	0.00117	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.000117	0.00113	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—FGD1—nicotine dependence	0.000117	0.00113	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	0.000116	0.00112	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	0.000116	0.00112	CbGpPWpGaD
Trimipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000115	0.00111	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000115	0.00111	CbGpPWpGaD
Trimipramine—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	0.000112	0.00108	CbGpPWpGaD
Trimipramine—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	0.000111	0.00107	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000111	0.00107	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	0.000111	0.00107	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	0.000107	0.00103	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—OPRM1—nicotine dependence	0.000106	0.00103	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000106	0.00102	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—AKR1B10—nicotine dependence	0.000103	0.000997	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	9.95e-05	0.000959	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	9.77e-05	0.000942	CbGpPWpGaD
Trimipramine—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	9.67e-05	0.000932	CbGpPWpGaD
Trimipramine—HRH1—GPCR ligand binding—DRD2—nicotine dependence	9.65e-05	0.00093	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	9.61e-05	0.000927	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	9.59e-05	0.000925	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	9.46e-05	0.000912	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	9.41e-05	0.000907	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	9.06e-05	0.000873	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	9.05e-05	0.000872	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	8.79e-05	0.000847	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	8.75e-05	0.000843	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	8.75e-05	0.000843	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—FGD1—nicotine dependence	8.73e-05	0.000842	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	8.7e-05	0.000838	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—FGD1—nicotine dependence	8.69e-05	0.000837	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—DRD2—nicotine dependence	8.48e-05	0.000817	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	8.33e-05	0.000803	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	8.32e-05	0.000801	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	8.23e-05	0.000793	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	7.99e-05	0.00077	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	7.94e-05	0.000765	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	7.9e-05	0.000761	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	7.71e-05	0.000743	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—DRD2—nicotine dependence	7.7e-05	0.000742	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	7.68e-05	0.00074	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	7.67e-05	0.00074	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—FGD1—nicotine dependence	7.67e-05	0.000739	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	7.56e-05	0.000729	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	7.56e-05	0.000728	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—FGD1—nicotine dependence	7.54e-05	0.000727	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	7.54e-05	0.000727	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—FGD1—nicotine dependence	7.53e-05	0.000726	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	7.4e-05	0.000713	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	7.39e-05	0.000712	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	7.35e-05	0.000708	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—WASF2—nicotine dependence	7.29e-05	0.000702	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—WASF1—nicotine dependence	6.99e-05	0.000673	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	6.97e-05	0.000672	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	6.87e-05	0.000662	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	6.86e-05	0.000661	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	6.86e-05	0.000661	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	6.85e-05	0.00066	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	6.77e-05	0.000653	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—CYP2A7—nicotine dependence	6.74e-05	0.00065	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	6.72e-05	0.000647	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	6.66e-05	0.000642	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	6.65e-05	0.000641	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	6.55e-05	0.000631	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	6.53e-05	0.000629	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	6.32e-05	0.000609	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	6.29e-05	0.000606	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—OPRM1—nicotine dependence	6.29e-05	0.000606	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	6.24e-05	0.000602	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	6.06e-05	0.000584	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	6.02e-05	0.00058	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	5.95e-05	0.000573	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	5.74e-05	0.000553	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	5.71e-05	0.000551	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	5.63e-05	0.000543	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	5.47e-05	0.000527	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	5.46e-05	0.000526	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	5.45e-05	0.000525	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—WASF2—nicotine dependence	5.44e-05	0.000524	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—WASF2—nicotine dependence	5.41e-05	0.000521	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	5.4e-05	0.00052	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	5.35e-05	0.000515	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—WASF1—nicotine dependence	5.21e-05	0.000502	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—WASF1—nicotine dependence	5.18e-05	0.0005	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	5.18e-05	0.000499	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	4.97e-05	0.000479	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	4.96e-05	0.000478	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	4.96e-05	0.000478	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—DRD2—nicotine dependence	4.95e-05	0.000477	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	4.86e-05	0.000468	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	4.86e-05	0.000468	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CYP2A7—nicotine dependence	4.78e-05	0.00046	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—WASF2—nicotine dependence	4.77e-05	0.00046	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—WASF2—nicotine dependence	4.7e-05	0.000452	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	4.69e-05	0.000452	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—WASF2—nicotine dependence	4.69e-05	0.000452	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	4.67e-05	0.00045	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CYP2A7—nicotine dependence	4.66e-05	0.000449	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	4.6e-05	0.000443	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—WASF1—nicotine dependence	4.58e-05	0.000441	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—DRD2—nicotine dependence	4.55e-05	0.000438	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	4.51e-05	0.000435	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—WASF1—nicotine dependence	4.5e-05	0.000434	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—WASF1—nicotine dependence	4.49e-05	0.000433	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	4.47e-05	0.000431	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	4.41e-05	0.000425	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	4.39e-05	0.000423	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CYP2A7—nicotine dependence	4.35e-05	0.00042	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	4.27e-05	0.000412	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—OPRM1—nicotine dependence	4.12e-05	0.000397	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	4.1e-05	0.000395	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	4.05e-05	0.000391	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—OPRM1—nicotine dependence	4.04e-05	0.00039	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	3.97e-05	0.000382	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	3.69e-05	0.000355	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	3.51e-05	0.000339	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—DRD2—nicotine dependence	3.39e-05	0.000327	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—DRD2—nicotine dependence	3.37e-05	0.000325	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	3.23e-05	0.000311	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—DRD2—nicotine dependence	2.93e-05	0.000282	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—DRD2—nicotine dependence	2.92e-05	0.000282	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	2.87e-05	0.000277	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	2.87e-05	0.000277	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	2.67e-05	0.000257	CbGpPWpGaD
